The A2Z Market Research report on “Global Biosimilars Market Report 2022 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029†offers strategic visions into the global Biosimilars market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2022 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Biosimilars product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for Biosimilars and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Biosimilars market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Biosimilars market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Biosimilars market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Biosimilars market are:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Market segmentation by Type:
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
Market segmentation by Application:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Table of Content
Global Biosimilars Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Market Segmentation by Type
1.2.1 Global Production Market Share of Biosimilars by Type in 2022
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Biosimilars Market Segmentation by Application
1.3.1 Biosimilars Consumption Market Share by Application in 2022
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Biosimilars Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Biosimilars (2018-2029)
Chapter 2 Global Economic Impact on Biosimilars Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Biosimilars Market Competition by Manufacturers
3.1 Global Biosimilars Production and Share by Manufacturers (2022 and 2022)
3.2 Global Biosimilars Revenue and Share by Manufacturers (2022 and 2022)
3.3 Global Biosimilars Average Price by Manufacturers (2022 and 2022)
3.4 Manufacturers Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Biosimilars Market Competitive Situation and Trends
3.5.1 Biosimilars Market Concentration Rate
3.5.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Biosimilars Production, Revenue (Value) by Region (2018-2022)
4.1 Global Biosimilars Production by Region (2018-2022)
4.2 Global Biosimilars Production Market Share by Region (2018-2022)
4.3 Global Biosimilars Revenue (Value) and Market Share by Region (2018-2022)
4.4 Global Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.5 North America Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.6 Europe Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.7 China Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.8 Japan Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.9 Southeast Asia Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
4.10 India Biosimilars Production, Revenue, Price and Gross Margin (2018-2022)
Chapter 5 Global Biosimilars Supply (Production), Consumption, Export, Import by Regions (2018-2022)
5.1 Global Biosimilars Consumption by Regions (2018-2022)
5.2 North America Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
5.3 Europe Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
5.4 China Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
5.5 Japan Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
5.6 Southeast Asia Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
5.7 India Biosimilars Production, Consumption, Export, Import by Regions (2018-2022)
Chapter 6 Global Biosimilars Production, Revenue (Value), Price Trend by Type
6.1 Global Biosimilars Production and Market Share by Type (2018-2022)
6.2 Global Biosimilars Revenue and Market Share by Type (2018-2022)
6.3 Global Biosimilars Price by Type (2018-2022)
6.4 Global Biosimilars Production Growth by Type (2018-2022)
Chapter 7 Global Biosimilars Market Analysis by Application
7.1 Global Biosimilars Consumption and Market Share by Application (2018-2022)
7.2 Global Biosimilars Consumption Growth Rate by Application (2018-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Biosimilars Manufacturing Cost Analysis
8.1 Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Biosimilars
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2022
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Biosimilars Market Forecast (2022-2029)
12.1 Global Biosimilars Production, Revenue Forecast (2022-2029)
12.2 Global Biosimilars Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Biosimilars Production Forecast by Type (2022-2029)
12.4 Global Biosimilars Consumption Forecast by Application (2022-2029)
12.5 Biosimilars Price Forecast (2022-2029)
Chapter 13 Appendix